{"disease":{"id":"relapsing-polychondritis","name":"relapsing polychondritis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT02257866","title":"Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT06873100","title":"Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05168475","title":"Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":true},{"nct_id":"NCT06019221","title":"Pediatric Relapsing Polychondritis : Diagnosis and Management in a French Retrospective Study","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04077736","title":"Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Peking University People's Hospital","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}